Transparency Market Research (TMR) observes that the Europe molecular diagnostics market is likely to see intensifying competition due to large number of players in the market. Companies are expected to focus on product differentiations and customizations to remain relevant in the competition. Thermo Fishcer Scientific and Bio-Rad Laboratories held a lion’s share in the regional market of about 50% in 2026. The leading companies will show a keen interest in mergers and acquisitions to expand their operations in the region.
According to the research report, the Europe molecular diagnostics market is expected to be worth US$769.0 mn by the end of 2025 from US$395.7 mn in 2016. Between the forecast years of 2017 and 2025, the regional market is expected to register a CAGR of 6.6%. Analysts expect that the real-time PCR systems segment will lead the pack as it is poised to be worth US$482.0 mn by the end of 2025. In terms of geography, Germany is expected to lead the Europe molecular diagnostics market as it accounts for US$185.2 mn in the regional market by the end of 2025.
Obtain Report Details @
Increasing Affordability of Diagnostics Propels Growth of Europe Molecular Diagnostics Market
Europe molecular diagnostics market has been burgeoning due to the steady rise of healthcare expenditure. The growing awareness about various chronic diseases and disorders, access of diagnostic centers, and rising affordability of diagnostics are some of the key factors propelling the growth of the regional market. The report states that the increasing support from the government, improving investments in research and development of advanced diagnostics, and high prevalence of infectious diseases are also likely to make a significant contribution to the soaring revenue of the Europe molecular diagnostics market.
The World Cancer Research Fund International states that Denmark registered highest number of cancer cases in Europe in 2012. This was closely followed by France, Belgium, Ireland, and the Netherlands. Thus, the high prevalence of cancer is expected to spike the demand for real-time PCR systems, which are the most preferred assays for the detection of these chronic conditions. The significant rise in product launches in Europe, especially in the field of automated liquid handling systems is likely to augment the demand for lab automation systems. This shift toward automation is expected to benefit market growth in the coming years. Additionally, the partnerships and collaborations between companies and research institutes to offer advanced products are expected to strengthen the market growth over the forecast period.
Difficulty of Sourcing Skilled Labor to Hamper Market Growth
On the flip side, the Europe molecular diagnostics market is being held back by a few factors. The key challenge for the players operating in the regional market is sourcing skilled labor, which is both expensive and scarce. Furthermore, as this skill gap worsens it is likely to make it tougher for the companies to keep their costs reasonable, which, in turn, will adversely impact revenue margins. The constantly growing need for new and improved technologies is also expected to act as an impediment for the molecular diagnostics market in Europe. For instance, adoption of next generation sequencing (NGS) is likely to discourage uptake of real-time PCR systems. Thus, these factors are likely to restrain the market from achieving its full potential. However, the market will have tremendous scope to grow as the demand for non-contact dispensing technologies is poised to augment the sale of liquid dispensing systems in the near future.
Fill the form for an exclusive sample of this report @
This review is based on Transparency Market Research’s report, titled “Molecular Diagnostics Market (Product - Real-time PCR Systems, Liquid Handling Systems, and DNA Extraction Systems; End User - Hospitals, Diagnostic Laboratories, Academic and Research Institutes, and Pharmaceutical and Biotechnology Companies) - Europe Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2017 - 2025.”
The Molecular Diagnostics Market has been segmented as follows:
- Molecular Diagnostics Market, by Product, Revenue (US$ Mn) and Volume (units) 2015-2025
- Real Time- PCR Systems
- LightCycler 480
- PCRmax Eco 48
- Applied Biosystems 7900HT
- QuantStudio Real-Time PCR
- ViiA 7 Real-Time PCR
- C1000 Touch
- ABI StepOnePlus Real-Time PCR
- 5ABI 7500
- AriaMx Real-time PCR System
- CFX Connect
- CFX384 Touch
- Liquid Handling System
- Freedom EVO
- Tecan D300e Digital Dispenser
- DNA Extraction System
- AutoMate Express
- Real Time- PCR Systems
- Molecular Diagnostics Market, by End-User, Revenue (US$ Mn) and Volume (units) 2015-2025
- Diagnostic Laboratories
- Academic and Research Institutes
- Pharmaceutical and Biotechnology Companies
- Molecular Diagnostics Market, by Country, Revenue (US$ Mn) 2015-2025
- Rest of Europe
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.